Literature DB >> 16882462

Apolipoprotein E genotype and gallbladder disease risk in a large population-based cohort.

Lori L Boland1, Aaron R Folsom, Eric Boerwinkle.   

Abstract

PURPOSE: The aim of the study is to describe the association between apolipoprotein E (apoE) genotype and gallbladder disease incidence.
METHODS: Cases of incident hospitalized gallbladder disease were ascertained in nearly 13,000 middle-aged men and women participating in the Atherosclerosis Risk in Communities (ARIC) Study, a prospective cohort study in four US communities.
RESULTS: Between the ARIC baseline examination (1987 to 1989) and December 31, 2001, a total of 639 participants were hospitalized for gallbladder disease. After adjustment for age, sex, race, obesity, plasma lipid level, and diabetes, the relative risk for hospitalized gallbladder disease associated with the presence of an epsilon4 allele (i.e., genotypes E4/4, E3/4, and E2/4 versus other genotypes) was 0.72 (95% confidence interval [CI], 0.60-0.87). Stratification by race showed that the inverse association with epsilon4 was stronger in whites (relative risk, 0.69; 95% CI, 0.56-0.85) than African Americans (relative risk, 0.86; 95% CI, 0.58-1.30). The presence of the other rare isoform, epsilon2 (i.e., genotypes E2/2, E2/3, and E2/4 versus others) was associated with a modest increased risk for gallbladder disease (relative risk, 1.28; 95% CI, 1.05-1.57).
CONCLUSIONS: These results suggest that independent of traditional risk factors, apoE genotype may influence gallbladder disease risk, particularly in whites. The exact biologic mechanism for such an association remains unclear and requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882462     DOI: 10.1016/j.annepidem.2006.04.005

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  6 in total

1.  Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China.

Authors:  Gabriella Andreotti; Idan Menashe; Jinbo Chen; Shih-Chen Chang; Asif Rashid; Yu-Tang Gao; Tian-Quan Han; Lori C Sakoda; Stephen Chanock; Philip S Rosenberg; Ann W Hsing
Journal:  Eur J Epidemiol       Date:  2009-11-04       Impact factor: 8.082

2.  Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.

Authors:  Gabriella Andreotti; Jinbo Chen; Yu-Tang Gao; Asif Rashid; Bingshu E Chen; Philip Rosenberg; Lori C Sakoda; Jie Deng; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Meredith Yeager; Robert Welch; Stephen Chanock; Joseph F Fraumeni; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02-22       Impact factor: 4.254

3.  Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.

Authors:  Lee E Moore; Paul Brennan; Sara Karami; Idan Menashe; Sonja I Berndt; Linda M Dong; Allison Meisner; Meredith Yeager; Stephen Chanock; Joanne Colt; Kendra Schwartz; Faith Davis; David Zaridze; Vsevolod Mattveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Ivana Holcatova; Paolo Boffetta; Wong-Ho Chow; Philip S Rosenberg; Nathaniel Rothman
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

4.  APOE and FABP2 Polymorphisms and History of Myocardial Infarction, Stroke, Diabetes, and Gallbladder Disease.

Authors:  Ikuko Kato; Susan Land; Jill Barnholtz-Sloan; Richard K Severson
Journal:  Cholesterol       Date:  2011-09-18

5.  Relationship of Gallbladder Diseases with Sociodemographic Characteristics, Lifestyle, and Chronic Diseases in Northeastern China.

Authors:  Qi Kang; Guojun Kang; Rixin Li; Xiaojing Zhu; Yaqin Yu; Qiong Yu
Journal:  Int J Environ Res Public Health       Date:  2018-11-21       Impact factor: 3.390

6.  The association between apolipoprotein E and gallstone disease: an updated meta-analysis.

Authors:  Lizhuo Li; Xin Qiao; Xia Wang; Di Liu; Qingmu Xue; Lu Han; Fei Dai; Guomin Ma; Zhipeng Yang; Tao Zhang; Shuo Yang; Shikang Cai; Mingyue Gao; Jingyun Yang
Journal:  BMC Med Genet       Date:  2019-06-14       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.